The Effect of Curcumin on Inflammatory Markers in Hemodialysis Patients

The goal of this clinical trial is to learn if curcumin can lower the inflammation in participants with chronic kidney disease (CKD) undergoing hemodialysis (HD). The main questions it aims to answer are: Does curcumin lower can lower profinflamatory markers in participants with CKD on HD? Researchers will compare curcumin to a placebo (a look-alike substance that contains no drug) to see if curcumin works to help the treatment in participants with CKD on HD. Researchers will compare nutritional status and side effects after taking the supplement. Participants will: Take the curcumin or a placebo twice a day for 3 months Visit the clinic once every week for checkups and tests.

NCT Number	NCT06829186
Lead Sponsor	University of Guadalajara Collaborators: Hospital Civil de Guadalajara
Conditions	Hemodialysis
Enrollment	70 participants
Start Date	2025-03-15
Primary Completion	2025-09-30 (estimated)
Study Completion	2026-12-30 (estimated)
Updated on ClinicalTrials.gov	2025-02-17